Rational Design of an Epidermal Growth Factor Receptor Vaccine: Immunogenicity and Antitumor Research
The epidermal growth factor receptor (EGFR) is frequently overexpressed in a variety of human epithelial tumors, and its aberrant activation plays a pivotal role in promoting tumor growth, invasion, and metastasis. The clinically approved passive EGFR-related therapies have numerous limitations. Sev...
Saved in:
| Main Authors: | Yifei Liu, Zehui Liu, Zhongliang Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/14/12/1620 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidermal growth factor receptor signaling governs the host inflammatory response to invasive aspergillosis
by: Hong Liu, et al.
Published: (2024-12-01) -
Multi-sequence MRI-based nomogram for prediction of human epidermal growth factor receptor 2 expression in breast cancer
by: Mengyi Shen, et al.
Published: (2025-02-01) -
A novel in-silico approach to design a multiepitope peptide as a vaccine candidate for Aeromonas hydrophila
by: Mahdieh SobhZahedi, et al.
Published: (2024-12-01) -
Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients
by: Yan-Jei Tang, et al.
Published: (2024-01-01) -
Epidermal growth factor and remarkable correlations in a case series COVID-19
by: Héctor José Pérez Hernández
Published: (2024-06-01)